Concentration-dependent bupivacaine myotoxicity in rabbit extraocular muscle

Cheng Zhang, Pittaya Phamonvaechavan, Anand Rajan, David Y. Poon, Pinar Topcu-Yilmaz, David L. Guyton

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Purpose: Bupivacaine myotoxicity to the extraocular muscles, from retrobulbar or peribulbar anesthesia, has been reported after cataract surgery and other intraocular procedures. However, there are no data on the concentration-dependence of bupivacaine in causing extraocular muscle toxicity. Methods: Six aged rabbits received different concentrations of bupivacaine (0.75% and lower) in 3 extraocular muscles, namely, superior rectus, inferior rectus, and inferior oblique muscles of each rabbit's eye. The animals were euthanized at 5 days or 1 month after the injections. Hematoxylin and eosin- and Masson trichrome-stained sections were obtained from the involved extraocular muscles after paraffin embedding. Results: Five days after the initial injection, the 0.75% bupivacaine-injected extraocular muscles showed extensive myonecrosis and degeneration with early-stage regenerating muscle fibers. However, muscle tissue injected with half-concentration bupivacaine (0.38%) showed scattered and significantly fewer areas of mild muscle fiber degeneration with regeneration. There were no areas of muscle tissue degeneration observed in any muscle injected with quarter-concentration bupivacaine (0.19%). At 1 month, however, only 0.75% bupivacaine-injected muscles displayed areas of regenerated muscle fiber cells with foci of scar formation. There was no visible scar formation in muscles injected with any bupivacaine concentration lower than 0.75%, or with saline, at 1 month after injection. Conclusions: Extraocular muscle injection with full-strength bupivacaine (0.75%) can cause myonecrosis and degeneration acutely, with regeneration appearing by 5 days, followed by some late-stage scar formation. However, no long-term effects were observed with bupivacaine concentrations of 0.38% or 0.19%.

Original languageEnglish (US)
Pages (from-to)323-327
Number of pages5
JournalJournal of AAPOS
Volume14
Issue number4
DOIs
StatePublished - Aug 2010
Externally publishedYes

Fingerprint

Oculomotor Muscles
Bupivacaine
Rabbits
Muscles
Cicatrix
Injections
Regeneration
Paraffin Embedding
Hematoxylin
Eosine Yellowish-(YS)
Cataract
Muscle Cells

ASJC Scopus subject areas

  • Ophthalmology
  • Pediatrics, Perinatology, and Child Health

Cite this

Zhang, C., Phamonvaechavan, P., Rajan, A., Poon, D. Y., Topcu-Yilmaz, P., & Guyton, D. L. (2010). Concentration-dependent bupivacaine myotoxicity in rabbit extraocular muscle. Journal of AAPOS, 14(4), 323-327. https://doi.org/10.1016/j.jaapos.2010.05.009

Concentration-dependent bupivacaine myotoxicity in rabbit extraocular muscle. / Zhang, Cheng; Phamonvaechavan, Pittaya; Rajan, Anand; Poon, David Y.; Topcu-Yilmaz, Pinar; Guyton, David L.

In: Journal of AAPOS, Vol. 14, No. 4, 08.2010, p. 323-327.

Research output: Contribution to journalArticle

Zhang, C, Phamonvaechavan, P, Rajan, A, Poon, DY, Topcu-Yilmaz, P & Guyton, DL 2010, 'Concentration-dependent bupivacaine myotoxicity in rabbit extraocular muscle', Journal of AAPOS, vol. 14, no. 4, pp. 323-327. https://doi.org/10.1016/j.jaapos.2010.05.009
Zhang, Cheng ; Phamonvaechavan, Pittaya ; Rajan, Anand ; Poon, David Y. ; Topcu-Yilmaz, Pinar ; Guyton, David L. / Concentration-dependent bupivacaine myotoxicity in rabbit extraocular muscle. In: Journal of AAPOS. 2010 ; Vol. 14, No. 4. pp. 323-327.
@article{9a5f74ac882a4f59918808098267b57b,
title = "Concentration-dependent bupivacaine myotoxicity in rabbit extraocular muscle",
abstract = "Purpose: Bupivacaine myotoxicity to the extraocular muscles, from retrobulbar or peribulbar anesthesia, has been reported after cataract surgery and other intraocular procedures. However, there are no data on the concentration-dependence of bupivacaine in causing extraocular muscle toxicity. Methods: Six aged rabbits received different concentrations of bupivacaine (0.75{\%} and lower) in 3 extraocular muscles, namely, superior rectus, inferior rectus, and inferior oblique muscles of each rabbit's eye. The animals were euthanized at 5 days or 1 month after the injections. Hematoxylin and eosin- and Masson trichrome-stained sections were obtained from the involved extraocular muscles after paraffin embedding. Results: Five days after the initial injection, the 0.75{\%} bupivacaine-injected extraocular muscles showed extensive myonecrosis and degeneration with early-stage regenerating muscle fibers. However, muscle tissue injected with half-concentration bupivacaine (0.38{\%}) showed scattered and significantly fewer areas of mild muscle fiber degeneration with regeneration. There were no areas of muscle tissue degeneration observed in any muscle injected with quarter-concentration bupivacaine (0.19{\%}). At 1 month, however, only 0.75{\%} bupivacaine-injected muscles displayed areas of regenerated muscle fiber cells with foci of scar formation. There was no visible scar formation in muscles injected with any bupivacaine concentration lower than 0.75{\%}, or with saline, at 1 month after injection. Conclusions: Extraocular muscle injection with full-strength bupivacaine (0.75{\%}) can cause myonecrosis and degeneration acutely, with regeneration appearing by 5 days, followed by some late-stage scar formation. However, no long-term effects were observed with bupivacaine concentrations of 0.38{\%} or 0.19{\%}.",
author = "Cheng Zhang and Pittaya Phamonvaechavan and Anand Rajan and Poon, {David Y.} and Pinar Topcu-Yilmaz and Guyton, {David L.}",
year = "2010",
month = "8",
doi = "10.1016/j.jaapos.2010.05.009",
language = "English (US)",
volume = "14",
pages = "323--327",
journal = "Journal of AAPOS",
issn = "1091-8531",
publisher = "Mosby Inc.",
number = "4",

}

TY - JOUR

T1 - Concentration-dependent bupivacaine myotoxicity in rabbit extraocular muscle

AU - Zhang, Cheng

AU - Phamonvaechavan, Pittaya

AU - Rajan, Anand

AU - Poon, David Y.

AU - Topcu-Yilmaz, Pinar

AU - Guyton, David L.

PY - 2010/8

Y1 - 2010/8

N2 - Purpose: Bupivacaine myotoxicity to the extraocular muscles, from retrobulbar or peribulbar anesthesia, has been reported after cataract surgery and other intraocular procedures. However, there are no data on the concentration-dependence of bupivacaine in causing extraocular muscle toxicity. Methods: Six aged rabbits received different concentrations of bupivacaine (0.75% and lower) in 3 extraocular muscles, namely, superior rectus, inferior rectus, and inferior oblique muscles of each rabbit's eye. The animals were euthanized at 5 days or 1 month after the injections. Hematoxylin and eosin- and Masson trichrome-stained sections were obtained from the involved extraocular muscles after paraffin embedding. Results: Five days after the initial injection, the 0.75% bupivacaine-injected extraocular muscles showed extensive myonecrosis and degeneration with early-stage regenerating muscle fibers. However, muscle tissue injected with half-concentration bupivacaine (0.38%) showed scattered and significantly fewer areas of mild muscle fiber degeneration with regeneration. There were no areas of muscle tissue degeneration observed in any muscle injected with quarter-concentration bupivacaine (0.19%). At 1 month, however, only 0.75% bupivacaine-injected muscles displayed areas of regenerated muscle fiber cells with foci of scar formation. There was no visible scar formation in muscles injected with any bupivacaine concentration lower than 0.75%, or with saline, at 1 month after injection. Conclusions: Extraocular muscle injection with full-strength bupivacaine (0.75%) can cause myonecrosis and degeneration acutely, with regeneration appearing by 5 days, followed by some late-stage scar formation. However, no long-term effects were observed with bupivacaine concentrations of 0.38% or 0.19%.

AB - Purpose: Bupivacaine myotoxicity to the extraocular muscles, from retrobulbar or peribulbar anesthesia, has been reported after cataract surgery and other intraocular procedures. However, there are no data on the concentration-dependence of bupivacaine in causing extraocular muscle toxicity. Methods: Six aged rabbits received different concentrations of bupivacaine (0.75% and lower) in 3 extraocular muscles, namely, superior rectus, inferior rectus, and inferior oblique muscles of each rabbit's eye. The animals were euthanized at 5 days or 1 month after the injections. Hematoxylin and eosin- and Masson trichrome-stained sections were obtained from the involved extraocular muscles after paraffin embedding. Results: Five days after the initial injection, the 0.75% bupivacaine-injected extraocular muscles showed extensive myonecrosis and degeneration with early-stage regenerating muscle fibers. However, muscle tissue injected with half-concentration bupivacaine (0.38%) showed scattered and significantly fewer areas of mild muscle fiber degeneration with regeneration. There were no areas of muscle tissue degeneration observed in any muscle injected with quarter-concentration bupivacaine (0.19%). At 1 month, however, only 0.75% bupivacaine-injected muscles displayed areas of regenerated muscle fiber cells with foci of scar formation. There was no visible scar formation in muscles injected with any bupivacaine concentration lower than 0.75%, or with saline, at 1 month after injection. Conclusions: Extraocular muscle injection with full-strength bupivacaine (0.75%) can cause myonecrosis and degeneration acutely, with regeneration appearing by 5 days, followed by some late-stage scar formation. However, no long-term effects were observed with bupivacaine concentrations of 0.38% or 0.19%.

UR - http://www.scopus.com/inward/record.url?scp=77956218274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956218274&partnerID=8YFLogxK

U2 - 10.1016/j.jaapos.2010.05.009

DO - 10.1016/j.jaapos.2010.05.009

M3 - Article

VL - 14

SP - 323

EP - 327

JO - Journal of AAPOS

JF - Journal of AAPOS

SN - 1091-8531

IS - 4

ER -